Analyst Ratings for Momenta Pharmaceuticals (MNTA) [Neutrals]
MNTA Rating Summary
MNTA Price Target Summary
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$20.38 (+52.2%)
Avg. $ Target:
$20.38 (+52.2%)
| Date | Firm | Type | Rating (Past) |
PT (Past) |
Start $ | End $ | % Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 7/20/2012 | UBS » Updated 8/6/2012 |
Downgrade | Neutral (Buy) |
14.00 (15.00) |
14.39 | 13.39 | -6.95% | Details |
| 6/25/2012 | Canaccord Genuity » Updated 8/6/2012 |
Downgrade | Hold (Buy) |
12.00 (12.00) |
13.50 | 13.39 | -0.81% | Details |
| 9/20/2011 | Cowen | Downgrade | Neutral (N/A) |
N/A (N/A) |
12.30 | 13.39 | 8.86% | Details |
| 12/20/2010 | Goldman Sachs » Updated 2/10/2012 |
New Coverage | Neutral (N/A) |
16.00 (N/A) |
15.45 | 13.39 | -13.33% | Details |
